Accuracy of Self-Reported Haemoglobin Genotype in a Rural Nigerian Community: Implications for Sickle Cell Disease Prevention
Abstract:
Background: In high-burden settings for sickle cell disease (SCD), many prevention strategies implicitly assume that adults who report “knowing their haemoglobin genotype” can accurately recall it. However, in rural Nigerian communities, where testing is often sporadic and post-test counselling inconsistent, the reliability of self-reported genotype remains poorly documented.
Objective: To assess the accuracy of self-reported haemoglobin genotype among adults in Benue South Senatorial District and to describe patterns of misclassification compared with laboratory-confirmed results.
Methods: A community-based cross-sectional study was conducted among 372 adults in three Local Government Areas of Benue South, Nigeria. Participants were asked whether they knew their haemoglobin genotype and, if yes, to state it (AA, AS, or SS). All participants provided venous blood for alkaline cellulose acetate haemoglobin electrophoresis, which served as the reference standard. Accuracy was defined as concordance between self-reported and laboratory-confirmed genotype among those who claimed awareness. Agreement was assessed using cross-tabulation and Fisher’s exact test.
Results: Only 32 of 372 respondents (8.6%) reported knowing their haemoglobin genotype. Among these, 26/32 (81.3%) correctly stated their laboratory-confirmed genotype, while 6/32 (18.7%) were incorrect (Fisher’s exact p = 0.008). Accuracy was highest among those reporting AA (22/25; 88.0%), moderate among those reporting AS (4/6; 66.7%), and absent in the single respondent who reported SS (0/1). Misclassification occurred in both directions, with some individuals with AS misreporting as AA and vice versa.
Conclusion: Although most individuals who claimed awareness correctly identified their genotype, nearly one in five were wrong. Reliance on self-report alone is therefore unsafe for premarital or antenatal counselling and community screening decisions. SCD prevention programmes should prioritise confirmatory testing, clearer post-test counselling, and written documentation of results rather than verbal self-declaration.
KeyWords:
sickle cell disease; haemoglobin genotype; accuracy; self-report; community screening; Nigeria.
References:
- World Health Organization. Sickle-cell disease (Fact sheet). Updated 6 Aug 2025.
- GBD 2021 Sickle Cell Disease Collaborators. Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000–2021. Lancet Haematol. 2023;10(8):e585–e599.
- Piel FB, Patil AP, Howes RE, et al. Global epidemiology of sickle haemoglobin in neonates. Lancet. 2013;381:142–151.
- Chakravorty S, Williams TN. Sickle cell disease: a neglected chronic disease of increasing global importance. Arch Dis Child. 2015;100:48–53.
- Federal Ministry of Health (Nigeria). National Guideline for the Control and Management of Sickle Cell Disease. Abuja; 2014.
- WHO Regional Office for Africa. Sickle cell disease: the silent killer in Africa. May 2024.
- Adewoyin AS, Alagbe AE, Adedokun BO, Idubor NT. Knowledge, attitude and control practices of SCD among youth corps members in Benin City. Ann Ib Postgrad Med. 2015;13:100–107.
- Akodu SO, Disu EA, Njokanma OF. Pattern and factors associated with genotype testing in Lagos. Niger J Gen Pract. 2015;13:16–20.
- Ezenwosu OU, Itanyi IU, Nnodu OE, et al. Community-based screening for sickle haemoglobin in Benue State. BMC Pregnancy Childbirth. 2021;21:498.
- Galadanci AA, Ibrahim UA, Carroll Y, et al. Novel newborn screening for SCD in Nigeria. Int J Neonatal Screen. 2024;10:67.
- Aondoaseer M, Mokuolu OA. Awareness and acceptability of newborn screening in Benue. Niger J Paediatr. 2025;52:256–266.
- Odunvbun ME, Okolo AA, Rahimy CM. Knowledge of sickle cell disease in Nigeria. Soc Sci Med. 2003;56:185–196.
- World Health Organization. Genetics and genomics in public health. Geneva; 2016.
- Weatherall DJ. The inherited diseases of haemoglobin are an emerging global health burden. Blood. 2010;115:4331–4336.
- McGann PT, Hernandez AG, Ware RE. Sickle cell anaemia in sub-Saharan Africa: advancing care through technology. Blood. 2017;129:1551–1557.
- Peters DH, Garg A, Bloom G, et al. Poverty and access to health care in developing countries. Ann NY Acad Sci. 2008;1136:161–171.
- World Health Organization. Universal health coverage and essential diagnostics. Geneva; 2023.